The FDA's April 30, 2026 proposal regarding compounded GLP-1 medications is subject to a public comment period and final regulatory determination expected later in 2026
You can use HSA or FSA funds to pay, but insurance isnt an option with Ivy Rx
Women make up 63% of our overall cohort (even higher for weight-loss) and show incredible health improvements lower incidence of key cancers and significant cardiovascular event reductions
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity
Most gastrointestinal side effects have resolved or become minimal by this stage
This article will compare the most effective GLP-1 receptor agonists, weighing their benefits and risks, to help you make an informed decision on the best option for weight loss